Studies on the active metabolite (DU-86) of KW-2189, a novel derivative of duocarmycin

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 17, 1996, Pages 2147-2150

  Nagamura, Satoru ^a   Kobayashi, Eiji ^a   Gomi, Katsushige ^a   Saito, Hiromitsu ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DU 86; DUOCARMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; SARCOMA 180; STRUCTURE ACTIVITY RELATION;

EID: 0030567868     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00388-5     Document Type: Article

References (26)

1. (a) Takahashi, I.; Takahashi, K.; Ichimura, M.; Morimoto, M., Asano, K.; Kawamoto, I.; Tomita, F.; Nakano, H. J. Antibiot. 1988, 41, 1915.
2. (b) Ichimura, M.; Muroi, K.; Asano, K., Kawamoto, I.; Tomita, F.; Morimoto, M.; Nakano, H. J. Antibiot. 1988, 41, 1285.
3. (c) Ichimura, M.; Ogawa, T.; Takahashi, K.; Kobayashi, E.; Kawamoto, I.; Yasuzawa, T.; Takahashi, I.; Nakano, H. J. Antibiot. 1990, 43, 1037.
4. (d) Ichimura, M.; Ogawa, T.; Katsumata, S.; Takahashi, K.; Takahashi, I.; Nakano, H. J. Antibiot. 1991, 44, 1045.
5. (a) Sugiyama, H.; Hosoda, M.; Saito, I.; Asai, A.; Saito, H. Tetrahedron Lett. 1990, 31, 7197.
6. (b) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H. J. Org. Chem. 1990, 55, 4499.
7. (c) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H.; Munk, S. A.; Kitos, P. A.; Suntornwat, O. J. Am. Chem. Soc. 1990, 112, 8961.
8. (d) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H. J. Am. Chem. Soc. 1991, 113, 6645.
9. (e) Sugiyama, H ; Ohmori, K.; Chan, K. L.; Hosoda, M.; Asai, A ; Saito, H.; Saito, I. Tetrahedron Lett. 1993, 34, 2179.
10. (a) Hanka, L. J.; Dietz, A.; Gerpheide, S. A., Kuentzel, S. L.; Martin, D. G. J. Antibiot. 1978, 31, 1211.
11. (b) Martin, D. G.; Chidester, C. G.; Duchamp, D. J.; Mizsak S. A. J. Antibiot. 1980, 33, 902.
12. Nagamura, S.; Kanda, Y.; Kobayashi, E.; Gomi, K.; Saito, H. Chem. Pharm. Bull. 1995, 43, 1530.
13. (a) Nagamura, S.; Asai, A.; Kanda, Y.; Kobayashi, E.; Gomi, K.; Saito, H. Chem. Pharm. Bull. 1996, in press,
14. (b) Kobayashi, E.; Okamoto, A.; Asada, M.; Okabe, M.; Nagamura, S.; Asai, A.; Saito, H.; Gomi, K.; Hirata, T. Cancer Res. 1994, 54, 2404.
15. (c) Asai, A.; Nagamura, S.; Saito, H. J. Am. Chem. Soc. 1994, 116, 4171.
16. (a) Nagamura, S.; Kobayashi, E.; Gomi, K.; Saito, H. Bioorg. Med. Chem. 1996, in press.
17. (b) Ogasawara, H.; Nishio, K.; Takeda, Y.; Ohmori, T.; Kubota, N.; Funayama, Y.; Ohira, T.; Kuraishi, Y.; Isogai, Y.; Saijo, N. Jpn. J. Cancer Res. 1994, 85, 418.
18. (c) Ogasawara, H.; Nishio, K.; Kanzawa, F.; Lee, Y-S.; Funayama, Y.; Ohira, T.; Kuraishi, Y.; Isogai, Y.; Saijo, N. Jpn. J. Cancer Res. 1995, 86, 124.
19. Nagamura, S.; Kanda, Y.; Asai, A.; Kobayashi, E.; Gomi, K.; Saito, H. Chem. Pharm. Bull. 1996, 44, 933.
20. 7: C, 63.80; H, 4.74; N, 8.58. Found: C, 63.99; H, 4.55; N, 8.71.
21. Hutchins, M.; Sainsbury, M.; Scopes, D. Tetrahedron 1984, 40, 1511.
22. (a) Geran, R. I.; Greenberg, N. H.; MacDonald, M. M.; Schumacher, A. M.; Abbott, B. J. Cancer Chemother. Rep. 1972, 3, 1.
23. (b) Inaba, M.; Kobayashi, T.; Tashiro, T.; Sakurai, Y.; Maruo, K.; Ohnishi, Y.; Ueyama, Y.; Nomura, T. Cancer 1989, 64, 1577.
24. 3CN had been so far used. Under this condition, a half life of 2, 4 and duocarmycin SA is 130, 150 and 330 h, respectively. However, 3 and 5 were not dissolved in this aqueous solution.
25. (a) Boger, D. L.; Yun, W. J. Am. Chem. Soc. 1994, 116, 5523.
26. (b) Boger, D. L.; McKie, J. A.; Han, N.; Tarby, C. M.; Riggs, H. W.; Kitos, P. A. Bioorg. Med Chem. Lett. 1996, 6, 659